RCKT logo

Rocket Pharmaceuticals (RCKT) Retained Earnings

Annual Retained Earnings

-$959.37 M
-$245.59 M-34.41%

December 31, 2023


Summary


Performance

RCKT Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTbalance sheetmetrics:

Quarterly Retained Earnings

-$1.16 B
-$66.72 M-6.12%

September 30, 2024


Summary


Performance

RCKT Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

RCKT Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-34.4%-28.7%
3 y3 years-197.2%-28.7%
5 y5 years-806.1%-28.7%

RCKT Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-95.0%at low-135.4%at low
5 y5-year-423.8%at low-532.2%at low
alltimeall time-806.1%at low-2379.3%at low

Rocket Pharmaceuticals Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$1.16 B(+6.1%)
Jun 2024
-
-$1.09 B(+6.8%)
Mar 2024
-
-$1.02 B(+6.5%)
Dec 2023
-$959.37 M(+34.4%)
-$959.37 M(+6.6%)
Sep 2023
-
-$899.71 M(+7.4%)
Jun 2023
-
-$837.81 M(+8.5%)
Mar 2023
-
-$772.11 M(+8.2%)
Dec 2022
-$713.77 M(+45.1%)
-$713.77 M(+10.3%)
Sep 2022
-
-$647.05 M(+9.8%)
Jun 2022
-
-$589.30 M(+10.2%)
Mar 2022
-
-$534.89 M(+8.7%)
Dec 2021
-$491.91 M(+52.4%)
-$491.91 M(+9.9%)
Sep 2021
-
-$447.67 M(+12.6%)
Jun 2021
-
-$397.55 M(+9.5%)
Mar 2021
-
-$363.02 M(+12.4%)
Dec 2020
-$322.84 M(+76.3%)
-$322.84 M(+23.3%)
Sep 2020
-
-$261.93 M(+12.5%)
Jun 2020
-
-$232.85 M(+12.0%)
Mar 2020
-
-$207.81 M(+13.5%)
Dec 2019
-$183.14 M
-$183.14 M(+12.2%)
Sep 2019
-
-$163.29 M(+13.4%)
DateAnnualQuarterly
Jun 2019
-
-$144.00 M(+14.9%)
Mar 2019
-
-$125.32 M(+18.4%)
Dec 2018
-$105.87 M(-60.6%)
-$105.87 M(+34.8%)
Sep 2018
-
-$78.55 M(+25.8%)
Jun 2018
-
-$62.47 M(+33.8%)
Mar 2018
-
-$46.70 M(-82.6%)
Dec 2017
-$268.37 M(+12.3%)
-$268.37 M(+1.8%)
Sep 2017
-
-$263.50 M(+2.9%)
Jun 2017
-
-$256.11 M(+2.6%)
Mar 2017
-
-$249.55 M(+4.5%)
Dec 2016
-$238.88 M(+21.9%)
-$238.88 M(+5.7%)
Sep 2016
-
-$225.90 M(+5.2%)
Jun 2016
-
-$214.78 M(+4.2%)
Mar 2016
-
-$206.09 M(+5.1%)
Dec 2015
-$196.02 M(+53.1%)
-$196.02 M(+4.4%)
Sep 2015
-
-$187.85 M(+42.4%)
Jun 2015
-
-$131.89 M(+1.8%)
Mar 2015
-
-$129.50 M(+1.1%)
Dec 2014
-$128.04 M(+8.0%)
-$128.04 M(+1.7%)
Sep 2014
-
-$125.89 M(+6.2%)
Dec 2013
-$118.51 M(+6.9%)
-$118.51 M
Dec 2012
-$110.89 M
-

FAQ

  • What is Rocket Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals annual retained earnings year-on-year change?
  • What is Rocket Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals quarterly retained earnings year-on-year change?

What is Rocket Pharmaceuticals annual retained earnings?

The current annual retained earnings of RCKT is -$959.37 M

What is the all time high annual retained earnings for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high annual retained earnings is -$105.87 M

What is Rocket Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, RCKT annual retained earnings has changed by -$245.59 M (-34.41%)

What is Rocket Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of RCKT is -$1.16 B

What is the all time high quarterly retained earnings for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high quarterly retained earnings is -$46.70 M

What is Rocket Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, RCKT quarterly retained earnings has changed by -$258.08 M (-28.68%)